0000000000019772

AUTHOR

Torello Lotti

showing 35 related works from this author

Trichostasis spinulosa misdiagnosed as alopecia areata.

2020

medicine.medical_specialtyAlopecia Areatabusiness.industryPruritusDermatologyGeneral MedicineKeratosisAlopecia areatamedicine.diseaseDermatologymedicineTrichostasis spinulosaHumansDiagnostic ErrorsbusinessHair DiseasesDermatologic therapyREFERENCES
researchProduct

A Brief Synopsis on Scalp Melanoma

2020

Melanoma constitutes one of the most sinister and troublesome malignancies encountered by humanity. Generally, the diagnosis of advanced melanoma connotes a grave prognosis, prompting a sense of looming threat of death, however, the early-stage detected disease responds well to robust treatment resulting in reasonable survivorship. Scalp melanomas are even more troublesome, because they typically exhibit more aggressive biologic behavior and are often diagnosed at a late stage. This review tries to comprehensively highlight the various diagnostic, therapeutic, and outcome aspects of scalp melanomas. The literature research includes peer-reviewed articles (clinical trials or scientific revie…

Melanomasmedicine.medical_specialtySkin NeoplasmsMEDLINEDermatologyEnglish languageDiseaseBreslow thickness; head and neck melanomas; melanomas; scalp melanomas; skin malignancies; Humans; Prognosis; Scalp; Head and Neck Neoplasms; Melanoma; Skin NeoplasmsBreslow thickne030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicinemedicineHumansMelanomaScalp melanomaAdvanced melanomaScalpHead and neck melanomabusiness.industryMelanomaLate stageHead and neck melanomasGeneral MedicinePrognosismedicine.diseaseDermatologyBreslow thickness; Head and neck melanomas; Melanomas; Scalp melanomas; Skin malignanciesClinical trialmedicine.anatomical_structureScalp melanomasHead and Neck NeoplasmsSkin malignancies030220 oncology & carcinogenesisScalpbusinessBreslow thickness
researchProduct

Learning from history: Coronavirus outbreaks in the past

2020

2019-20 coronavirus outbreakbiologybusiness.industryMiddle East respiratory syndrome coronavirusSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)OutbreakDermatologyGeneral Medicinemedicine.disease_causebiology.organism_classificationVirologyPandemicMedicinebusinessCoronavirus InfectionsBetacoronavirusCoronavirusDermatologic Therapy
researchProduct

Interleukin 23p19 inhibitors in chronic plaque psoriasis with focus on mirikizumab: A narrative review.

2020

Psoriasis, a T-cell mediated chronic dermatosis, has a complex etiopathogenesis. There has been extensive research into the aberrant immune response, which leads to the formation of clinical lesions, and the need for developing better and safer drugs has been unrelenting. The past two decades of research has opened up new areas of the immune pathway that can be targeted in order to control the disease. Therefore, we have seen the emergence of biologics which either target T-cell receptors or inhibit Tumor Necrosis Factor-alpha (TNF-α) or inhibit interleukins (IL) like IL-12, IL-17, IL-17 receptor, and more recently IL-23. Drugs specifically targeting the p19 subunit of IL-23 have shown prom…

Plaque psoriasisCell signalingbusiness.industryInterleukinDermatologyGeneral MedicineDiseasemedicine.diseaseAntibodies Monoclonal HumanizedInterleukin-23030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineImmune system030220 oncology & carcinogenesisPsoriasisImmunologymedicineHumansPsoriasisTh17 CellsTumor necrosis factor alphaReceptorbusinessDermatologic therapyREFERENCES
researchProduct

Therapeutic options in vitiligo with special emphasis on immunomodulators: A comprehensive update with review of literature

2020

Vitiligo is a relatively common disorder characterized by areas of depigmented skin. It may be associated with social stigma and adversely affects the quality of life. Although many treatment options are available, none is curable. The search continues for an effective therapeutic option. New targeted options include biologics and other immunomodulatory agents, with varying degrees of evidence. We have discussed briefly the therapeutic options with special emphasis on the newer immunomodulatory agents. We undertook a comprehensive English literature search across multiple databases such as PubMed, SCOPUS, EMBASE, MEDLINE, and Cochrane using keywords (alone and in combination) and MeSH items…

medicine.medical_specialtybusiness.industryVitiligoMEDLINETreatment optionsDermatologyGeneral MedicineVitiligomedicine.diseaselaw.invention030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineRandomized controlled triallaw030220 oncology & carcinogenesisQuality of LifemedicineHumansImmunologic FactorsProspective StudiesIntensive care medicinebusinessPUVA TherapyDermatologic Therapy
researchProduct

Update in minimally invasive periorbital rejuvenation with a focus on platelet-rich plasma: A narrative review.

2020

Background The periorbital region is among the first areas to be affected by the process of aging, which is influenced by genetic and constitutional factors. As the region plays an important role in overall facial appearance, rejuvenation of the area has immense cosmetic benefit and various treatment modalities have been used to achieve the same. Aims This article reviews commonly used non-surgical and minimally invasive modalities for periorbital rejuvenation. Methods The literature research considered published journal articles (clinical trials or scientific reviews). Studies were identified by searching electronic databases (MEDLINE and PubMed) and reference lists of respective articles.…

medicine.medical_specialtyMEDLINEDermatologyCosmetic TechniquesPeriorbital rejuvenation030207 dermatology & venereal diseases03 medical and health sciencesBlood Transfusion Autologous0302 clinical medicineMedicineHumansRejuvenationRejuvenationModalitiesModality (human–computer interaction)business.industryPlatelet-Rich PlasmaDermatologySkin AgingClinical trialTreatment Outcome030220 oncology & carcinogenesisPlatelet-rich plasmaFaceNarrative reviewbusinessJournal of cosmetic dermatologyREFERENCES
researchProduct

Safety of the current drug treatments for vitiligo

2020

Introduction: Vitiligo is an acquired depigmenting skin disorder adversely affecting the patient's quality of life. Despite the presence of several treatment modalities, ranging from medical to physical to surgical options, none is curative. Each modality has its own drawbacks and side effects. Thus, the treatment modality needs to be tailored for each individual patient taking into consideration the disease characteristics and also its efficacy and safety to obtain a favorable risk-benefit ratio.Areas covered: This review highlights the different treatment modalities utilized in vitiligo up until 4 November 2019 along with their adverse effects and contraindications, if any.Expert opinion:…

Drugmedicine.medical_specialtymedia_common.quotation_subjectVitiligoVitiligo030204 cardiovascular system & hematologyAdministration Cutaneous03 medical and health sciences0302 clinical medicineQuality of life (healthcare)Adrenal Cortex HormonesmedicineHumansEffective treatmentPharmacology (medical)Intensive care medicineAdverse effectmedia_commonBiological ProductsModality (human–computer interaction)business.industryGeneral Medicinemedicine.diseaseTreatment modality030220 oncology & carcinogenesisQuality of LifeDisease characteristicsDermatologic AgentsbusinessExpert Opinion on Drug Safety
researchProduct

Allergic contact dermatitis in patients with frontal fibrosing alopecia: An international multi‐center study

2020

Frontal fibrosing alopecia (FFA) mainly affects the anterior hairline and eyebrows and its etiology and associated factors remain obscure. The aim of this study was to evaluate the allergic contact dermatitis with patch test in patients with FFA. In this prospective study, 20 patients with FFA and 24 age and sex-matched healthy individuals were evaluated with patch testing. Diagnosis was made histologically, clinically and based on dermoscopic findings. Demographic data, age of onset, disease duration and FFA severity index are evaluated in all patients. Positive patch test reaction to one or more allergen was observed in 65% of patients while it was 37.5% in control group (P = .003). There…

medicine.medical_specialtyDermatologymedicine.disease_cause030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineAllergenQuality of lifemedicineHumansProspective StudiesProspective cohort studyAllergic contact dermatitisbusiness.industryFrontal fibrosing alopeciaLichen PlanusPatch testAlopeciaGeneral Medicinemedicine.diseaseDermatology030220 oncology & carcinogenesisDermatitis Allergic ContactQuality of LifeEtiologyAge of onsetbusinessDermatologic Therapy
researchProduct

Cutaneous and Allergic reactions due to COVID‐19 vaccinations: A review

2021

ABSTRACT Introduction The pandemic caused by the novel coronavirus disease 2019 (COVID‐19) has had an unprecedented impact on the overall health and the global economy. Vaccination is currently the most dependable strategy to end the pandemic, despite the slower‐than‐hoped‐for rollout, particularly for low‐to‐middle‐income countries, and the uncertain duration of protection afforded by vaccination. The spike protein of the virus (immunodominant antigen of the virus) is the main target of the approved and candidate SARS‐CoV‐2 vaccines. This protein binds to the ACE2 receptor of the host cell, initiating the entry of the virus into the cell and the chain of subsequent events ending to Acute R…

medicine.medical_specialtyAllergyCOVID-19 VaccinesCoronavirus disease 2019 (COVID-19)ExacerbationReview ArticleDermatologyallergic reactionsmedicine.disease_causeSARS‐CoV‐2VirusAntigenCOVID‐19PandemicHypersensitivityHumansMedicineIntensive care medicineReview ArticlesCoronavirusbusiness.industryVaccinationCOVID-19cutaneous reactionsmedicine.diseaseVaccinationBNT162b2mRNA VaccinesbusinessJournal of Cosmetic Dermatology
researchProduct

Penile burn due to sulfuric acid: A case report

2020

chemistry.chemical_compoundmedicine.medical_specialtychemistrybusiness.industryMEDLINEMedicineSulfuric acidDermatologyGeneral MedicinebusinessDermatologyDermatologic Therapy
researchProduct

Low dose of isotretinoin: A comprehensive review

2020

Isotretinoin is a first-generation retinoid initially approved for the treatment of severe cases of acne vulgaris (nodulocystic acne). Because of its broad anti-inflammatory and immunomodulatory properties, it has been used beyond its initial approval in a myriad of other indications. Adverse effects of isotretinoin vary from xerosis to teratogenicity. Herein, we reviewed the literature, through date-unlimited PubMed search, from inception till December 2019, using the following search terms: "low-dose isotretinoin" and "dermatology," "isotretinoin and safety," "isotretinoin, off-label uses," "isotretinoin and male fertility," "isotretinoin, iPLEDGE system," aiming to deliver a therapeutic …

Malemedicine.medical_specialtyNodulocystic acneDermatologyRetinoids030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineAcne VulgarismedicineHumansIsotretinoinskin and connective tissue diseasesAdverse effectIsotretinoinAcnebusiness.industryLow doseGeneral Medicinemedicine.diseaseDermatologyClinical PracticeSafety profileSearch terms030220 oncology & carcinogenesisDermatologic Agentsbusinessmedicine.drugDermatologic Therapy
researchProduct

Postherpetic neuralgia and recalcitrant cystic lesions following herpes zoster: A case report and review of treatment options.

2020

Acute herpes zoster lesions in most cases are self-limited except in older and immunocompromised patients, wherein the pain can cause significant suffering. Postherpetic neuralgia is a painful situation for patients that can compromise the quality of life. Here, we report a 30-year-old healthy young man who developed treatment-resistant postherpetic neuralgia after herpes zoster (fourth/fifth thoracic segment) without any underlying immunocompromised state. He also developed some cystic lesions, which were removed by aspiration and surgery. The skin lesions improved 2 weeks after the surgery and postherpetic neuralgia was completely cured after 5 months, however cystic lesions recurred mult…

AdultMalemedicine.medical_specialtyNeuralgia PostherpeticDermatologyHerpes Zoster030207 dermatology & venereal diseases03 medical and health sciencesCystic lesion0302 clinical medicineRecurrencemedicineHumansTreatment resistantAgedPostherpetic neuralgiabusiness.industryTreatment optionsGeneral Medicinemedicine.diseaseDermatologynervous system diseasesbody regions030220 oncology & carcinogenesisQuality of LifeSkin lesionbusinessDermatologic therapyREFERENCES
researchProduct

STAT3 ‐mutated hyperimmunoglobulin E syndrome with perianal skin tags and erosions: A case report

2020

medicine.medical_specialtybiologyPerianal skin tagsbusiness.industrymedicinebiology.proteinDermatologyGeneral MedicineHyperimmunoglobulin E syndromemedicine.diseasebusinessSTAT3DermatologyDermatologic Therapy
researchProduct

Pharmaceutical promotion and guided-prescription in low- and middle-income countries: A need for new regulations.

2020

Economic growthbusiness.industrymedia_common.quotation_subjectMEDLINEDeveloping countryDermatologyGeneral MedicinePromotion (rank)PrescriptionsPharmaceutical PreparationsLow and middle income countriesMedicineHumansMedical prescriptionbusinessDeveloping Countriesmedia_commonDermatologic therapy
researchProduct

5‐Alpha reductase inhibitors in androgenetic alopecia: Shifting paradigms, current concepts, comparative efficacy, and safety

2020

Androgenetic alopecia (AGA) is a multifactorial disease that carries a significant psychological burden with it. Dihydrotestosterone, the main pathogenic androgen in AGA, is produced by conversion of testosterone, which is catalyzed by the 5-alpha reductase (5-AR) isoenzyme family. Finasteride and dutasteride are inhibitors of these enzymes. Finasteride, which is a single receptor 5-alpha reductase inhibitor (5-ARI), acts by blocking dihydrotestosterone (DHT). Dutasteride, a dual receptor DHT blocker, has a higher potency than its predecessor, finasteride. This review corroborates the evidence of superiority of dutasteride over finasteride, and its comparable safety profile concerning ferti…

medicine.drug_classDermatologyReductasePharmacology030207 dermatology & venereal diseases03 medical and health sciences5 Alpha-Reductase Inhibitorchemistry.chemical_compound5-alpha Reductase Inhibitors0302 clinical medicinemedicineHumansTestosteronebusiness.industryFinasterideNeurotoxicityAlopeciaAndrogen AntagonistsGeneral MedicineDutasterideDutasteridemedicine.diseaseAndrogenchemistry030220 oncology & carcinogenesisDihydrotestosteroneFinasteridebusinessmedicine.drugDermatologic Therapy
researchProduct

Complications of botulinum toxin and fillers: A narrative review

2019

Background Cosmetic surgery and esthetic procedures have become a billion dollar industry owing to the ever-growing demand of the population to stay young. The injectable treatments including fillers and botulinum toxin have become highly popular because of their quick, predictable and lasting results in the management of facial wrinkles and rejuvenation. Although these treatment modalities are relatively safe, they are associated with certain side effects. Aims In this review, we will focus on the complications of fillers and botulinum toxin. Patients/methods The literature research considered published journal articles (clinical trials or scientific reviews). Studies were identified by se…

medicine.medical_specialtyEcchymosisPopulationMEDLINEFacial MusclesCosmetic TechniquesDermatologyPain ProceduralInjections030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineDermal FillersHumansMedicineBotulinum Toxins Type AeducationIntensive care medicineAdverse effecteducation.field_of_studybusiness.industryBotulinum toxinInjection Site ReactionClinical trialFacial AsymmetryNeuromuscular Agents030220 oncology & carcinogenesisBrow ptosisNarrative reviewEyebrowsmedicine.symptombusinessmedicine.drugJournal of Cosmetic Dermatology
researchProduct

Review of biologics in allergic contact dermatitis

2020

The resistant and recalcitrant nature of severe allergic contact dermatitis (ACD) makes its management challenging. With advances in the understanding of the cellular and molecular pathogenesis of ACD, newer therapeutic targets are becoming apparent. In particular, the use of biologics has gained momentum, given the specificity of their action. This article aims to review the presently available data on the use of biologics in ACD. English-language-based literature available on the use of biological therapy was thoroughly probed in the following databases as on October 14, 2019: PubMed, Google Scholar, The Cochrane library, Embase, Scopus, and EBSCO. The following keywords were used: "conta…

medicine.medical_specialtyDermatologyOmalizumabEtanercept030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineUstekinumabmedicineAdalimumabHumansImmunology and Allergy030212 general & internal medicineAllergic contact dermatitisBiological Productsbusiness.industryPatch Testsmedicine.diseaseDermatologyDupilumabInfliximabTreatment OutcomeDermatitis Allergic ContactSecukinumabbusinessmedicine.drugContact Dermatitis
researchProduct

Solidarity and transparency against the COVID ‐19 pandemic

2020

2019-20 coronavirus outbreakLetterCoronavirus disease 2019 (COVID-19)business.industryDeveloped CountriesInternational CooperationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia ViralCOVID-19DermatologyGeneral MedicinePublic administrationTransparency (behavior)SolidarityPandemicHumansMedicineLettersCoronavirus InfectionsbusinessDelivery of Health CareDeveloping CountriesPandemicsDermatologic Therapy
researchProduct

Uncommon presentation of pigmented paraungual basal cell carcinoma on the first toe treated with total excision

2020

Basal cell carcinomas (BCCs) are the most common types of skin neoplasm. The finger, toe, and nail unit are uncommon and rare locations of BCC. Only a few patients with foot BCC have been reported, and ungual BCC is even less frequent. We present a patient with a BCC on the left first toe. Clinically, it appeared as a brown-colored plaque with an irregular border on the nail fold and dorsum of the left thumb. Histopathological findings were consistent with the pigmented type of BCC. Surgical approach with subsequent full thickness mesh graft led to a complete remission. Follow-up at 10 months revealed a functionally and cosmetically acceptable outcome. The clinical presentation of nail unit…

medicine.medical_specialtySkin Neoplasmintegumentary systemUngualbusiness.industryfungiComplete remissionLeft thumbDermatologyGeneral Medicinemedicine.diseaseDermatology030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicinemedicine.anatomical_structure030220 oncology & carcinogenesisNail (anatomy)medicineMesh graftBasal cell carcinomaPresentation (obstetrics)skin and connective tissue diseasesbusinessDermatologic Therapy
researchProduct

Selective RAR agonists for acne vulgaris: A narrative review.

2019

Background Acne vulgaris is a chronic disfiguring inflammatory disease of adolescents and adults affecting up to 90% of the population around the world. The sequence of etiopathogenesis in acne is not completely understood but involves abnormalities in sebum production, follicular plugging, proliferation of propionibacterium acnes, and chronic inflammation. Aims This review aims to summarize the features of the topical selective RAR agonists in treating acne vulgaris with a special emphasis on the 4th generation topical retinoid trifarotene. Methods Studies were identified by searching electronic databases (MEDLINE and PubMed) till August 2019 and reference lists of respective articles. Onl…

medicine.medical_specialtymedicine.drug_classReceptors Retinoic AcidPopulationTretinoinDermatologyAdministration Cutaneous030207 dermatology & venereal diseases03 medical and health sciencesPropionibacterium acnesRetinoids0302 clinical medicineMaintenance therapyTazaroteneAdapaleneAcne VulgarisMedicineHumansRetinoidAdapaleneeducationAcneRandomized Controlled Trials as Topiceducation.field_of_studybiologybusiness.industryNicotinic Acidsbiology.organism_classificationmedicine.diseaseDermatologyTreatment OutcomeTolerability030220 oncology & carcinogenesisDermatologic Agentsbusinessmedicine.drugJournal of cosmetic dermatologyREFERENCES
researchProduct

Efficacy of 595- and 1319-nm pulsed dye laser in the treatment of acne vulgaris: a narrative review

2020

Acne is one of the commonest problems of adolescence with almost half of the patients experiencing persistence into adulthood. Pulsed dye lasers (PDL) with wavelengths of 585 and 595 nm targeting hemoglobin have been used for the treatment of this condition and its sequelae. Recent introduction of PDL with a higher wavelength of 1319 nm has been reported to offer some benefit to acne patients. We reviewed the literature on the use of 595-nm and 1319-nm PDL in the management of acne. A PubMed literature search for search terms "pulsed dye laser," "acne laser therapy," "light therapy for acne," "595 nm and acne," "1319 nm and acne" was done. Studies, series and case reports were included. The…

AdolescentLasers DyeLasers Solid-StateDermatologylaw.inventionPulsed dye030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicinestomatognathic systemlawAcne VulgarisHumansMedicineAcneDye laserbusiness.industryLasermedicine.diseaseTreatment OutcomePhotochemotherapy030220 oncology & carcinogenesisOptoelectronicsSurgeryNarrative reviewLaser TherapybusinessJournal of Cosmetic and Laser Therapy
researchProduct

COVID ‐19: A relationship to climate and environmental conditions?

2020

2019-20 coronavirus outbreakLetterCoronavirus disease 2019 (COVID-19)SARS-CoV-2business.industryClimateSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia ViralMEDLINECOVID-19DermatologyGeneral MedicineComputational biologyBetacoronavirusHumansMedicineLettersCoronavirus InfectionsbusinessPandemicsWeatherDermatologic Therapy
researchProduct

Carboxytherapy in dermatology.

2022

Abstract Carboxytherapy is a medical technique during which a sterile gas—carbon dioxide—is injected into the subdermal tissue. The utility of carbon dioxide injections has enhanced the practical relevance of carboxytherapy as a method for the management of multiple disorders. We have evaluated its use in the treatment of dermatologic conditions by searching electronic databases (ie, MEDLINE and PubMed) for contributions in the English language through January 2021. Carboxytherapy provides an attractive aesthetic option in skin rejuvenation, atrophic scars, striae distensae (stretch marks), cellulite-fibrolipodystrophy adhesions after liposuction, and certain types of alopecia. We discuss t…

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentMEDLINEAtrophic scarsEnglish languageDermatologyCarbon Dioxidemedicine.diseaseDermatologyMultiple disordersStretch marksLiposuctionmedicineStriae distensaeHumansmedicine.symptomCellulitebusinessStriae DistensaeRejuvenationSkinClinics in dermatology
researchProduct

A cross‐sectional, multi‐center study on treatment of facial acne scars with low‐energy double‐pass 1450‐nm diode laser

2020

Acne scars are the ultimate outcome of acne vulgaris, a prevalent skin disorder affecting the pilo-sebaceous unit. Laser resurfacing has been demonstrated to be an efficient therapy option for acne scars. Hence, we adopted this concept and conducted a study to evaluate the safety and efficacy of low-energy double-pass 1450-nm diode laser on acne scars. This study was conducted on 48 patients with acne scars, treated at 4-week interval with low-energy double-pass 1450-nm diode laser. Patients were evaluated clinically and with photographs, at day 0, first month and third month post the final treatment and during follow-up visit. Five treatment sessions were completed by all patients. Approxi…

medicine.medical_specialtyDermatologyDouble passlaw.inventionCicatrix030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineLow energylawAcne VulgarisHumansMedicineAcne scarsAcnebusiness.industryLaser treatmentGeneral MedicineLasermedicine.diseaseHyperpigmentationDermatologyCross-Sectional StudiesTreatment Outcome030220 oncology & carcinogenesisMulti center studyLaser TherapyLasers Semiconductormedicine.symptombusinessDermatologic Therapy
researchProduct

Priorities for global health community in COVID ‐19 pandemic

2020

medicine.medical_specialty2019-20 coronavirus outbreakLetterCoronavirus disease 2019 (COVID-19)Health PersonnelPneumonia ViralMEDLINEDermatologyGlobal HealthHealth personnelPandemicmedicineGlobal healthHumansLettersIntensive care medicinePandemicsbusiness.industryViral EpidemiologyCOVID-19General Medicinemedicine.diseasePneumoniaCoronavirus InfectionsbusinessDelivery of Health CareDermatologic Therapy
researchProduct

COVID-19 and economy.

2020

2019-20 coronavirus outbreakChinaLetterCoronavirus disease 2019 (COVID-19)business.industryViral EpidemiologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia ViralMEDLINECOVID-19DermatologyGeneral Medicinemedicine.diseaseGlobal HealthVirologyPneumoniaMedicineHumansLettersbusinessCoronavirus InfectionsPandemicsDermatologic therapy
researchProduct

Predatory journals: The silent intruder.

2019

medicine.medical_specialtybusiness.industryFamily medicinemedicineMEDLINEHumansDermatologyGeneral MedicinePeriodicals as TopicbusinessDermatologic therapy
researchProduct

Emerging drugs for the treatment of vitiligo.

2020

Introduction: Vitiligo is a relatively common autoimmune depigmenting disorder of the skin. There has been a great advance in understanding the pathological basis, which has led to the development and utilization of various new molecules in treating vitiligo. This review aims at a comprehensively describing the treatments available and the emerging treatment aspects and the scope for future developments.Areas covered: This study comprehensively summarizes the current concepts in the pathogenesis of vitiligo with special focus on the cytokine and signaling pathways, which are the targets for newer drugs. JAK kinase signaling pathways and the cytokines involved are the focus of vitiligo treat…

MAP Kinase Signaling SystemAdministration TopicalVitiligoAdministration OralVitiligoBiologicsBioinformatics030226 pharmacology & pharmacy03 medical and health scienceschemistry.chemical_compound0302 clinical medicineClinical Trials Phase II as TopicLocalized vitiligoMedicineHumansJanus Kinase InhibitorsPharmacology (medical)skin and connective tissue diseasesRandomized Controlled Trials as TopicPharmacologytreatmentintegumentary systembusiness.industrymedicine.diseaseCombined Modality TherapyJAK inhibitorchemistryClinical Trials Phase III as Topic030220 oncology & carcinogenesisCytokinesAfamelanotideDermatologic AgentsbusinessJanus kinaseBiologics; JAK inhibitor; treatment; vitiligoExpert opinion on emerging drugs
researchProduct

Psoriatic arthritis and COVID ‐19 pandemic: Consequences in medical treatment?

2020

The COVID‐19 pandemic has a strong negative impact on human society world‐wide. Patients with immune‐mediated disease may be prone to an increased risk of infection and/ or more severe course. We review the available data for patients with psoriatic arthritis (PSA) and systemic treatments. Current treatment options are summarized. Based upon the experience with COVID‐19 the following problems are addressed: (a) Can systemic treatment reduce comorbidities of PsA that are also comorbidities for COVID‐19? Does systemic medical treatment pose an increased risk of infection with SARS‐CoV‐2? Does systemic drug therapy have an impact on the risk of pulmonary fibrosis ‐ a factor with strong negativ…

Special Issue Articlesmedicine.medical_specialtyDiseaseComorbidityDermatologyPlacebo030207 dermatology & venereal diseases03 medical and health sciencesPsoriatic arthritisPsoriatic arthritis; systemic medical treatment0302 clinical medicinePharmacotherapyCOVID‐19Internal medicinePandemicmedicineHumansJanus Kinase InhibitorsbiologicsBiological Productsbusiness.industrySARS-CoV-2Tumor Necrosis Factor-alphaArthritis PsoriaticInterleukinSpecial Issue ArticleCOVID-19General Medicinemedicine.diseaseComorbiditysmall molecules030220 oncology & carcinogenesisAirwaybusinessDermatologic Therapy
researchProduct

The COVID-19 outbreak and rheumatologic skin diseases.

2020

2019-20 coronavirus outbreakLetterCoronavirus disease 2019 (COVID-19)business.industryClinical Laboratory TechniquesSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia ViralMEDLINEOutbreakCOVID-19DermatologyGeneral MedicineVirologySkin DiseasesDisease OutbreaksArthritis RheumatoidCOVID-19 TestingRisk FactorsMedicineHumansLettersbusinessCoronavirus InfectionsPandemicsDermatologic therapy
researchProduct

Simvastatin in vitiligo: an update with recent review of the literature.

2021

Patients with vitiligo often seek medical attention, as it diminishes their quality of life resulting in significant morbidity. Several topical and systemic therapies are in vogue targeting the immunological aspect of this disease, but results are often unsatisfactory, and complete cure remains elusive. Recently, simvastatin, a 3-hydroxy-3-methylyglutaryl-coenzyme A (HMG-CoA) reductase inhibitor, is being evaluated for vitiligo management because of its multimodal action, easy availability, and low cost. The proposed multimodal actions range from anti-inflammatory, antioxidant, to immunomodulatory properties which may be of therapeutic benefit in vitiligo patients. The authors intend to eva…

medicine.medical_specialtySimvastatinintegumentary systembusiness.industryVitiligoDermatologyDiseaseVitiligomedicine.disease030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineQuality of lifeSimvastatin030220 oncology & carcinogenesismedicineQuality of LifeHumansHydroxymethylglutaryl-CoA Reductase Inhibitorsskin and connective tissue diseasesIntensive care medicinebusinessMedical attentionmedicine.drugInternational journal of dermatologyReference
researchProduct

Italian Euromelanoma Day Screening Campaign (2005-2007) and the planning of melanoma screening strategies.

2011

Although no study has definitively shown that unfocused screening of skin cancer is effective, many campaigns have been organized with the aim of increasing awareness on melanoma risk factors. The objective of this study was to analyse the results of the Skin Cancer Screening Day in Italy during the period 2005-2007, to determine the priorities for melanoma control plans in a Mediterranean country. A total of 5002 patients were screened by dermatologists in 31 cities. Individuals who considered themselves to have many naevi and those with a family history of melanoma showed a higher number of common and atypical naevi. Ten melanomas, 20 basal cell carcinomas and two squamous cell carcinomas…

Program evaluationMaleCancer ResearchSkin NeoplasmsTime FactorsEpidemiologyBasal CellpreventionRisk Factorsself-surveillance80 and overSettore MED/35 - Malattie Cutanee E VenereeMedicineMass Screeningmelanoma screening campaignMelanoma prevention strategy Melanoma risk factors Melanoma screening campaign Self-surveillance Skin cancerFamily historyYoung adultChildMelanomaAged 80 and overeducation.field_of_studyNevus Pigmentedskin cancerMelanomaMiddle AgedMALIGNANT MELANOMA; screeningPrognosisOncologyItalymelanoma; screening; risk factors; prevention; prognosisChild PreschoolCarcinoma Squamous CellFemaleAdultmedicine.medical_specialtyAdolescentPopulationmelanoma prevention strategy; melanoma risk factors; melanoma screening campaign; self-surveillance; skin cancermelanoma prevention strategyYoung AdultPigmentedHumansmelanoma prevention strategy; melanoma risk factors; melanoma screening campaign; skin cancer; self-surveillancePreschooleducationNevusSocioeconomic statusMass screeningAgedbusiness.industrymelanoma risk factorsscreeningCarcinomaPublic Health Environmental and Occupational Healthmelanoma risk factorInfantmedicine.diseaseDermatologyMALIGNANT MELANOMASquamous CellCarcinoma Basal CellSelf-ExaminationSkin cancerbusinessProgram Evaluation
researchProduct

Alopecia areata and isotretinoin; coincidence or causal relation

2020

Isotretinoin is a safe and useful medication for acne management. Adverse effects are mostly related to cutaneous and mucous membranes. We present a case of a 24-year-old female patient who was on treatment with isotretinoin for acne vulgaris Grade 4. After 6 months of treatment, the patient presented with localized patch of hair loss. Beginning of alopecia areata in patients with acne vulgaris could be regarded as a side effect of retinoids due to anti-acne therapy. The exact mechanism by which retinoids cause hair loss is not known.

medicine.medical_specialtyintegumentary systemSide effectbusiness.industryCausal relationsDermatologyGeneral MedicineAlopecia areatamedicine.diseaseDermatologyHair lossMedicineIn patientskin and connective tissue diseasesbusinessAdverse effectIsotretinoinAcnemedicine.drugDermatologic Therapy
researchProduct

COVID ‐19 in the pediatric population

2020

Pediatricsmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Pneumonia ViralMEDLINEDermatologySeverity of Illness IndexPregnancyRisk FactorsPandemicSeverity of illnessmedicineHumansChildPandemicsPregnancyViral Epidemiologybusiness.industryAge FactorsInfant NewbornCOVID-19InfantGeneral Medicinemedicine.diseasePneumoniaFemalebusinessCoronavirus InfectionsPediatric populationDermatologic Therapy
researchProduct

Acanthosis nigricans: A review.

2020

Background Acanthosis nigricans (AN) is a cutaneous disorder characterized by symmetric velvety hyperpigmented plaques on intertriginous areas like axilla, neck, inframammary, and groin. Aims To summarize the pathophysiology and classification of AN, provide an update of diagnostic testing strategies, and describe the current therapeutic options described so far in the literature for this disease. Methods A comprehensive english language literature search across multiple databases (PubMed, EMBASE, MEDLINE, and Cochrane) for keywords (alone and in combination) was performed. MeSH as well as non-MeSH terms such as "acanthosis nigricans," "classification," "pathophysiology," "diagnosis," "trea…

medicine.medical_specialtyKeratolyticMEDLINEDermatologyDiseaseIntertriginous030207 dermatology & venereal diseases03 medical and health sciencesRetinoids0302 clinical medicinemedicineInframammary foldHumansAcanthosis NigricansObesityVitamin DAcanthosis nigricansbusiness.industrymedicine.diseaseDermatologyAxillamedicine.anatomical_structure030220 oncology & carcinogenesisChemical peelingInsulin ResistancebusinessJournal of cosmetic dermatologyREFERENCES
researchProduct